10-Q Filing

APPLIED BIOSCIENCES CORP. CIK: 1607549 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001477932-20-000724`
Period End Date	20191231
Filing Date	20200218
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	appb-20191231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 84 Cash Flow Statement 60 Stockholders Equity 61

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$21.27K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$60.93K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$47.04K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$241.57K	USD	Point-in-time
Unrelated parties net of debt discount	`UnrelatedPartiesNetOfDebtDiscount`	-	USD	Point-in-time
Unrelated parties net of debt discount	`UnrelatedPartiesNetOfDebtDiscount`	$153.17K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$163.41K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$76.20K	USD	Point-in-time
Inventory	`InventoryNet`	$78.74K	USD	Point-in-time
Preferred stock, shares par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Inventory	`InventoryNet`	$101.52K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$65.27K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Prepaids and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.67K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$354.46K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$213.66K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentOtherNet`	$331.32K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentOtherNet`	$452.05K	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$350.75K	USD	Point-in-time
Common stock, shares par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Equity investments	`EquityMethodInvestments`	$570.91K	USD	Point-in-time
Equity investments	`EquityMethodInvestments`	$898.29K	USD	Point-in-time
Goodwill (provisional)	`Goodwill`	$1.94M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.40M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	14.10M	shares	Point-in-time
Goodwill (provisional)	`Goodwill`	$1.94M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.40M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	14.10M	shares	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$5.50K	USD	Point-in-time
Other asset	`OtherAssetsNoncurrent`	$10.13K	USD	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	408,805.00	shares	Point-in-time
Common stock shares to be issued	`CommonStockSharesToBeIssued`	808,805.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.65M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.42M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$659.68K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$278.55K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$25.00K	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$25.00K	USD	Point-in-time
Convertible note payable - related party	`ConvertibleNotePayableRelatedParty`	$192.00K	USD	Point-in-time
Convertible note payable - related party	`ConvertibleNotePayableRelatedParty`	-	USD	Point-in-time
Convertible note payable - unrelated parties, net of debt discount of $153,170 at December 31, 2019	`ConvertibleNotesPayableCurrent`	$346.77K	USD	Point-in-time
Convertible note payable - unrelated parties, net of debt discount of $153,170 at December 31, 2019	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Derivative liability	`DerivativeLiabilities`	-	USD	Point-in-time
Derivative liability	`DerivativeLiabilities`	$234.06K	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$89.14K	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Accrued expenses	`OtherAccruedLiabilitiesCurrent`	$472.13K	USD	Point-in-time
Accrued expenses	`OtherAccruedLiabilitiesCurrent`	$70.72K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$374.27K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.02M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$261.62K	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.28M	USD	Point-in-time
Total Liabilities	`Liabilities`	$374.27K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at December 31, 2019 (unaudited) and 2018 and March 31, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding at December 31, 2019 (unaudited) and 2018 and March 31, 2019, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized: 14,100,956 issued and outstanding at December 31, 2019 (unaudited) and 13,397,110 at March 31, 2019	`CommonStockValue`	$143.00	USD	Point-in-time
Common stock; $0.00001 par value; 200,000,000 shares authorized: 14,100,956 issued and outstanding at December 31, 2019 (unaudited) and 13,397,110 at March 31, 2019	`CommonStockValue`	$135.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$6.89M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$7.32M	USD	Point-in-time
Common stock to be issued, 808,805 shares at December 31, 2019 (unaudited) and 408,805 shares at March 31, 2019	`CommonStockCapitalSharesReservedForFutureIssuance`	993,807.00	shares	Point-in-time
Common stock to be issued, 808,805 shares at December 31, 2019 (unaudited) and 408,805 shares at March 31, 2019	`CommonStockCapitalSharesReservedForFutureIssuance`	773,807.00	shares	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-5.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-8.09M	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.27K	USD	Point-in-time
Total Applied BioSciences Corp. Stockholders' Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.13M	USD	Point-in-time
Non-controlling equity	`NoncontrollingInterestInVariableInterestEntity`	$1.14M	USD	Point-in-time
Non-controlling equity	`NoncontrollingInterestInVariableInterestEntity`	$908.26K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$3.28M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$1.14M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$669.44K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$-1.63M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$650.38K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$2.85M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$648.32K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$2.16M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.65M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.42M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Products	`Product`	$413.11K	USD	1 Quarter
Products	`Product`	$22.36K	USD	1 Quarter
Products	`Product`	$192.01K	USD	3 Qtrs
Products	`Product`	$472.51K	USD	3 Qtrs
Services	`Service`	$147.22K	USD	1 Quarter
Services	`Service`	$433.30K	USD	3 Qtrs
Services	`Service`	-	USD	1 Quarter
Services	`Service`	-	USD	3 Qtrs
Total revenues, net	`Revenues`	$625.31K	USD	3 Qtrs
Total revenues, net	`Revenues`	$413.11K	USD	1 Quarter
Total revenues, net	`Revenues`	$169.57K	USD	1 Quarter
Total revenues, net	`Revenues`	$472.51K	USD	3 Qtrs
Products	`Products`	$439.74K	USD	3 Qtrs
Products	`Products`	$379.58K	USD	1 Quarter
Products	`Products`	$167.55K	USD	3 Qtrs
Products	`Products`	$17.14K	USD	1 Quarter
Services	`Services`	$34.21K	USD	1 Quarter
Services	`Services`	-	USD	3 Qtrs
Services	`Services`	-	USD	1 Quarter
Services	`Services`	$81.97K	USD	3 Qtrs
Total costs of revenue	`CostOfRevenue`	$249.51K	USD	3 Qtrs
Total costs of revenue	`CostOfRevenue`	$379.58K	USD	1 Quarter
Total costs of revenue	`CostOfRevenue`	$51.34K	USD	1 Quarter
Total costs of revenue	`CostOfRevenue`	$439.74K	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$32.77K	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$118.23K	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$375.79K	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$33.53K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$100.73K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$556.17K	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$256.77K	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$50.59K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.27M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$997.05K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.32M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.71M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$877.00	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$292.00	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$40.83K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$120.32K	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.65M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$1.42M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$1.09M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.27M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-2.27M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-2.24M	USD	3 Qtrs
OPERATING LOSS	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-970.24K	USD	1 Quarter
Change in fair value of equity investments	`UnrealizedGainLossOnInvestments`	$-327.38K	USD	1 Quarter
Change in fair value of equity investments	`UnrealizedGainLossOnInvestments`	$404.76K	USD	3 Qtrs
Change in fair value of equity investments	`UnrealizedGainLossOnInvestments`	$-327.38K	USD	3 Qtrs
Change in fair value of equity investments	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Change in fair value of derivative	`ChangeInFairValueOfDerivative`	$-39.23K	USD	1 Quarter
Change in fair value of derivative	`ChangeInFairValueOfDerivative`	$-34.98K	USD	3 Qtrs
Change in fair value of derivative	`ChangeInFairValueOfDerivative`	-	USD	1 Quarter
Change in fair value of derivative	`ChangeInFairValueOfDerivative`	-	USD	3 Qtrs
Interest Expense	`InterestExpense`	$-89.02K	USD	1 Quarter
Interest Expense	`InterestExpense`	$-153.82K	USD	3 Qtrs
Interest Expense	`InterestExpense`	$-506.58K	USD	1 Quarter
Interest Expense	`InterestExpense`	$-574.88K	USD	3 Qtrs
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-516.18K	USD	3 Qtrs
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-455.63K	USD	1 Quarter
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-506.58K	USD	1 Quarter
Total other (expense), net	`OtherNonoperatingIncomeExpense`	$-170.12K	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-2.79M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.43M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-2.41M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Less: Net income (loss) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$72.48K	USD	1 Quarter
Less: Net income (loss) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$234.00K	USD	3 Qtrs
Less: Net income (loss) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-234.00	USD	1 Quarter
Less: Net income (loss) attributable to non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$9.36K	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-2.56M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-1.35M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-2.40M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO APPLIED BIOSCIENCES CORP.	`IncomeLossAttributableToParent`	$-1.89M	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	3 Qtrs
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	1 Quarter
LOSS PER COMMON SHARE	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.80M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.56M	shares	3 Qtrs
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.65M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	11.15M	shares	3 Qtrs

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.79M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.41M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.89M	USD	1 Quarter
Change in fair value of equity investments	`ChangeInFairValueOfEquityInvestments`	$327.38K	USD	3 Qtrs
Change in fair value of equity investments	`ChangeInFairValueOfEquityInvestments`	$-404.76K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$437.81K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$123.29K	USD	3 Qtrs
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	$34.98K	USD	3 Qtrs
Change in fair value of derivative	`DerivativeGainLossOnDerivativeNet`	-	USD	3 Qtrs
Fair value of shares issued to consultants	`FairValueOfSharesIssuedToConsultants`	$649.30K	USD	3 Qtrs
Fair value of shares issued to consultants	`FairValueOfSharesIssuedToConsultants`	$321.00K	USD	3 Qtrs
Fair value of shares issued to officers and board member	`StockIssuedDuringPeriodValueOther`	$151.00K	USD	3 Qtrs
Fair value of shares issued to officers and board member	`StockIssuedDuringPeriodValueOther`	$756.25K	USD	3 Qtrs
Depreciation	`Depreciation`	$120.72K	USD	3 Qtrs
Depreciation	`Depreciation`	$878.00	USD	3 Qtrs
Allowance for bad debt	`AllowanceForBadDebt`	$33.46K	USD	3 Qtrs
Allowance for bad debt	`AllowanceForBadDebt`	-	USD	3 Qtrs
Amortization of operating lease right-of-use asset	`FinanceLeaseRightOfUseAssetAmortization`	$21.74K	USD	3 Qtrs
Amortization of operating lease right-of-use asset	`FinanceLeaseRightOfUseAssetAmortization`	-	USD	3 Qtrs
Repayment of lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	-	USD	3 Qtrs
Repayment of lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$-21.74K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-5.44K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$53.75K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-41.03K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-22.79K	USD	3 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$77.70K	USD	3 Qtrs
Prepaid and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$45.97K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$782.55K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$147.49K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-817.72K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-788.86K	USD	3 Qtrs
Deposit on acquisition	`EscrowDepositDisbursementsRelatedToPropertyAcquisition1`	-	USD	3 Qtrs
Deposit on acquisition	`EscrowDepositDisbursementsRelatedToPropertyAcquisition1`	$-550.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-550.00K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromIssuanceOfConvertibleNotes`	$791.94K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromIssuanceOfConvertibleNotes`	$1.44M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$75.00K	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.52M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$791.94K	USD	3 Qtrs
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$180.64K	USD	3 Qtrs
NET CHANGE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-25.78K	USD	3 Qtrs
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$21.27K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$60.93K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$47.04K	USD	Point-in-time
CASH, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$241.57K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$21.27K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$60.93K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$47.04K	USD	Point-in-time
CASH, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$241.57K	USD	Point-in-time
Fair value of common stock issued upon conversion of convertible notes and accrued interest	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNotesAndAccruedInterest`	$1.44M	USD	3 Qtrs
Fair value of common stock issued upon conversion of convertible notes and accrued interest	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNotesAndAccruedInterest`	$100.00K	USD	3 Qtrs
Fair value of beneficial conversion feature related to issuance of convertible notes	`FairValueOfBeneficialConversionFeatureRelatedToIssuanceOfConvertibleNotes`	$437.81K	USD	3 Qtrs
Fair value of beneficial conversion feature related to issuance of convertible notes	`FairValueOfBeneficialConversionFeatureRelatedToIssuanceOfConvertibleNotes`	$77.38K	USD	3 Qtrs
Initial recognition of operating lease right-of-use assets and operating lease obligations under adoption of ASC Topic 842	`InitialRecognitionOfOperatingLeaseRightOfUseAssetsAndOperatingLeaseObligationsUnderAdoptionOfAscTopic842`	-	USD	3 Qtrs
Initial recognition of operating lease right-of-use assets and operating lease obligations under adoption of ASC Topic 842	`InitialRecognitionOfOperatingLeaseRightOfUseAssetsAndOperatingLeaseObligationsUnderAdoptionOfAscTopic842`	$372.49K	USD	3 Qtrs
Recognition of derivative liability upon issuance of note payable	`RecognitionOfDerivativeLiabilityUponIssuanceOfNotePayable`	$199.08K	USD	3 Qtrs
Recognition of derivative liability upon issuance of note payable	`RecognitionOfDerivativeLiabilityUponIssuanceOfNotePayable`	-	USD	3 Qtrs

Stockholders Equity 61 line items

Line Item	Tag	Value	Unit	Period
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, amount	`StockholdersEquity`	$3.28M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$1.14M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$669.44K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.63M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$650.38K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.85M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$648.32K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.16M	USD	Point-in-time
Fair value of shares issued to consultant for services, amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$15.93K	USD	1 Quarter
Fair value of shares issued to consultant for services, amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$356.45K	USD	1 Quarter
Fair value of shares issued to consultant for services, amount	`FairValueOfSharesIssuedToConsultantForServicesAmount`	$225.93K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.43M	USD	1 Quarter
Net loss	`ProfitLoss`	$-401.76K	USD	1 Quarter
Net loss	`ProfitLoss`	$-113.76K	USD	1 Quarter
Net loss	`ProfitLoss`	$-507.93K	USD	1 Quarter
Net loss	`ProfitLoss`	$-855.23K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.89M	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`BeneficialConversionFeatureAssociatedWithAConvertibleNote`	$28.70K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`BeneficialConversionFeatureAssociatedWithAConvertibleNote`	$99.90K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`BeneficialConversionFeatureAssociatedWithAConvertibleNote`	$309.20K	USD	1 Quarter
Beneficial conversion feature associated with a convertible note	`BeneficialConversionFeatureAssociatedWithAConvertibleNote`	$77.38K	USD	1 Quarter
Fair value of shares issued to consultant for services, shares	`FairValueOfSharesIssuedToConsultantForServicesShares`	-	shares	1 Quarter
Fair value of shares issued to consultant for services, shares	`FairValueOfSharesIssuedToConsultantForServicesShares`	-	shares	1 Quarter
Fair value of shares issued to advisory board member, amount	`FairValueOfSharesIssuedToAdvisoryBoardMemberAmount`	$51.00K	USD	1 Quarter
Issuance of common stock for cash	`IssuanceOfCommonStockForCash`	$75.00K	USD	1 Quarter
Issuance of common stock previously committed but not issues, amount	`IssuanceOfCommonStockPreviouslyCommittedButNotIssuesAmount`	-	USD	1 Quarter
Conversion of convertible debt	`ConversionOfConvertibleDebt`	$1.44M	USD	1 Quarter
Fair value of shares issued to Company Officers and board member, amount	`FairValueOfSharesIssuedToCompanyOfficersAndBoardMemberAmount`	$756.25K	USD	1 Quarter
Fair value of shares issued to Company Officers and board member, shares	`FairValueOfSharesIssuedToCompanyOfficersAndBoardMemberShares`	-	shares	1 Quarter
Fair value of common stock issued upon conversion of convertible note	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNote`	$100.00K	USD	1 Quarter
Fair value of common stock issued to former board member, amount	`FairValueOfCommonStockIssuedToFormerBoardMemberAmount`	$70.00K	USD	1 Quarter
Fair value of common stock issued to officers, shares	`FairValueOfCommonStockIssuedToOfficerShares`	-	shares	1 Quarter
Fair value of common stock issued to officers, amount	`FairValueOfCommonStockIssuedToOfficersAmount`	$81.00K	USD	1 Quarter
Fair value of common stock issued upon conversion of convertible note, amount	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNoteAmount`	-	USD	1 Quarter
Fair value of common stock issued upon conversion of convertible note, shares	`FairValueOfCommonStockIssuedUponConversionOfConvertibleNoteShares`	-	shares	1 Quarter
Fair value of common stock issued to consultants, amount	`FairValueOfCommonStockIssuedToConsultantsAmount`	$321.00K	USD	1 Quarter
Fair value of common stock issued to consultants, shares	`FairValueOfCommonStockIssuedToConsultantsShares`	-	shares	1 Quarter
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, shares	`SharesIssued`	-	shares	Point-in-time
Balance, amount	`StockholdersEquity`	$3.28M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$1.14M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$669.44K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.63M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$650.38K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.85M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$648.32K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$2.16M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.